Viatris Inc. buy melinda
Start price
04.10.17
/
50%
€34.35
Target price
29.12.17
€42.39
Performance (%)
10.68%
End price
29.12.17
€38.02
Summary
This prediction ended on 29.12.17 with a price of €38.02. The prediction had a final performance of 10.68%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viatris Inc. | -2.419% | -2.419% | 42.242% | 32.620% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
Comments by melinda for this prediction
In the thread Viatris Inc. diskutieren
Der Kurs MYL Mylan Inc. zu folgen hat einen neuen Höchststand von 26 Wochen erreicht
$$
Die Mylan Inc MYL Preis hat einen neuen Höchststand von 26 Wochen erreicht
NV Mylan (MYL) gewinnt FDA - Zulassung für die erste Generation Copaxone; Die Aktie stieg um 17%
(Vom Mitglied beendet)